PATH-03. CLINICAL UTILITY OF NEXT GENERATION SEQUENCING IN IDH-WILDTYPE GLIOBLASTOMA: THE DANA-FARBER CANCER INSTITUTE EXPERIENCE

BACKGROUND: Comprehensive next generation sequencing (NGS) is available through many academic institutions and commercial entities, and is incorporated in practice guidelines for glioblastoma (GBM). We retrospective evaluated the practice patterns and utility of incorporating NGS data into routine c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Jane Lim-Fat, Mary, Youssef, Gilbert, Touat, Mehdi, Iorgulescu, Bryan, Woodward, Eleanor, Whorral, Sydney, Allen, Marie, Vogelzang, Jayne, Pisano, William, Rahman, Rifaquat, Chukwueke, Ugonma, Mcfaline-Figueroa, Jose, Nayak, Lakshmi, Lee, Eudocia, Batchelor, Tracy, Chiocca, E Antonio, Meredith, David, Santagata, Sandro, Reardon, David, Beroukhim, Rameen, Bi, Wenya Linda, Ligon, Keith, Wen, Patrick
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2020
Materias:
Molecular Pathology & Classification
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650887/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.685
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares